Anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: Comparison of Age-related Macular Degeneration Treatments Trials 5 year outcomes and implication for clinical practice.
- Resource Type
- Editorial
- Authors
- Chong, Elaine W; Al‐Qureshi, Salmaan H
- Source
- Clinical & Experimental Ophthalmology. May2017, Vol. 45 Issue 4, p333-335. 3p.
- Subject
- *VASCULAR endothelial growth factor antagonists
*RETINAL degeneration treatment
*CLINICAL trials
*VISUAL acuity
*CLINICAL trials monitoring
- Language
- ISSN
- 1442-6404
The article discusses 5 years treatment trials regarding the Anti-vascular Endothelial Growth Factor Treatment of Neovascular Age-related Macular Degeneration: The Comparison of Age-related Macular Degeneration Treatments Trials (CATT 5). Topics discussed include treatment outcomes with anti-vascular endothelial growth factor (anti-VEGF) and usage of fluorescein angiography.